The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R01 | Nasal preparations | |
| 3 | R01A | Decongestants and other nasal preparations for topical use | |
| 4 | R01AB | Sympathomimetics, combinations excl. corticosteroids | |
| 5 | R01AB06 | Xylometazoline |
| Active Ingredient | Description | |
|---|---|---|
| Xylometazoline |
Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
